What Does the “Most Favored Nation” Executive Order Mean for Personal Use Imports?
FDA Law Blog: Biosimilars
MAY 13, 2025
Section 5 of the May 12 EO states that within 30 days, HHS will communicate MFN price targets to pharmaceutical manufacturers to bring prices for patients in line with comparably developed nations. (We note our departure from more light-hearted content and absence of musical references. Please bear with us.) 62,094, 62,097 (Oct.
Let's personalize your content